PHARMACY

J&J announces tender offer to buyout Omrix Biopharma stock

BY Alaric DeArment

NEW BRUNSWICK, N.J. Johnson & Johnson said Tuesday that it would be making a tender offer to purchase all outstanding shares of common stock of New York-based biotech Omrix Biopharmaceuticals in an offer worth about $438 million in cash.

Upon the successful closing of the offer, Omrix stockholders will receive $25 per share of Omrix common stock tendered in the offer, minus required holding taxes. Omrix will operate as a stand-alone company reporting through Johnson & Johnson subsidiary Ethicon.

J&J said it would file a tender offer statement with terms of the offer with the Securities and Exchange Commission. The offer will expire at midnight on Dec. 23.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

King announces acquisition of Alpharma

BY Alaric DeArment

BRISTOL, Tenn. King Pharmaceuticals will acquire Alpharma in a deal worth $1.6 billion, King said Monday.

Alpharma had rejected a $33-per-share bid King made earlier, but accepted the most recent $37-per-share bid.

Alpharma, based in Bridgewater, N.J., has lately sought regulatory approval for painkillers designed to thwart abuse, such as Remoxy, a liquid capsule-based formulation of oxycodone.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Viagra under investigation for effect on athletes

BY Alaric DeArment

NEW YORK The World Anti-Doping Agency is investigating whether the drug Viagra gives athletes a competitive advantage on the playing field.

The drug, known generically as sildenafil citrate and made by Pfizer, works by opening the blood vessels. According to published reports, some experts have said this could give athletes more endurance by increasing the bloodstreams ability to deliver oxygen.

If studies indicate that Viagra does give athletes an advantage, WADA will consider listing it as a performance-enhancing drug.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?